ALB and coronary artery disorder: Data from a prospective cohort study enrolling 734 patients with stable coronary artery disease stratified by baseline serum ALB concentration in the low serum albumin group (<3.5 g/dL, n = 98) and in the normal albumin group (≥3.5 g/dL, n = 636), demonstrated that lower baseline serum albumin was related to an increased risk of all-cause mortality (10.2 vs. 0.5%, p < 0.001) and serious CV events (7.1 vs. 1.4%, p < 0.001) regardless of comorbidities and demographic characteristics (all-cause mortality, HR 6.81, 95% CI 1.01–45.62; hard CV events, HR 3.68, 95% CI 1.03–13.19) [41].